CIK 0001401914 · Non-accelerated filer<br>Smaller reporting company
Dare Bioscience, Inc.
Sign in to watch- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 204139823
- Phone
- 858-926-7655
- Business address
- 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 14,935 shares (grant or award)
- 4 Grant or award Director acquired 24,350 shares (grant or award)
- 4 Grant or award Director acquired 16,234 shares (grant or award)
- 4 Grant or award Director acquired 1,948 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 5,733 shares (grant or award)
- 4 Grant or award Director acquired 4,870 shares (grant or award)
- 4 Grant or award Director acquired 7,467 shares (grant or award)
- CT ORDER Other Confidential Order
- CT ORDER Other Confidential Order
- 8-K Event Delisting notice
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 11,274 shares (grant or award)
Page 28 of 39 · 778 filings